You are here: Home / Products
suPARnostic® is the only CE-IVD certified product range applied for clinical determination of suPAR (soluble uPAR) in human plasma and serum.
suPARnostic® is a prognostic biomarker useful for risk stratification of acute medical patients across diseases.
Important clinical benefits include:
- Advance identification of high-risk patients with unaffected vital signs
- Identification of patients who can be discharged after treatment
- Helps to prioritize patients and reduce Emergency Department crowding
suPARnostic® also improves the efficiency of the Emergency Department by shortening the average patient-length-of-stay which lead to cost savings.
The suPARnostic® brand consists of the following 3 products:
For Automated Systems
Quick Triage Test
A Point of Care Solution
For Clinical and Research Use